Rhenovia Pharma is a new R&D pharmaceutical and biotechnology company created on May 3, 2007. It is headquartered at Mulhouse, 20c rue de chemnitz, France. It has been founded by an international team highly committed to find new solutions to treat Alzheimer's disease (AD) and other diseases of the nervous system (NS). To address the urgent medical and societal needs, Rhenovia is offering service-partnership opportunities for pharmaceutical and biotechnology companies to provide new solutions for specific drug discovery programs.